Conduction abnormalities during dipyridamole stress testing

Samia Massalha; Ilya Reizberg; Ora Israel; Michael Kapeliovich; Haitham Sholy; Amjad Koskosi; Zohar Keidar; Ibrahim Marai

doi:10.1007/s12350-015-0294-1

Conduction abnormalities during dipyridamole stress testing

Samia Massalha, Ilya Reizberg, Ora Israel, Michael Kapeliovich, Haitham Sholy, Amjad Koskosi, Zohar Keidar, Ibrahim Marai

Technion-Israel Institute of Technology

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Pharmacological stress tests using dipyridamole are considered to be safe. However, cases of atrioventricular (AV) block have been reported. We retrospectively analyzed ECG at baseline and during dipyridamole stress tests of 2010 consecutive patients (patients with second or third degree AV block were excluded). At baseline, 350 (17.4%) patients had conduction abnormalities. Following dipyridamole infusion 16 patients (0.8%) developed a transient change in AV conduction (15 patients) and or sinus arrest (1 patient). Compared to patients without baseline conduction abnormalities, patients with any conduction abnormalities at baseline were at a higher risk for the development of AV block after dipyridamole infusion [0.3% vs 3.14%, respectively; P < .0001].

Original language	English
Pages (from-to)	405-409
Number of pages	5
Journal	Journal of Nuclear Cardiology
Volume	24
Issue number	2
DOIs	https://doi.org/10.1007/s12350-015-0294-1
State	Published - 1 Apr 2017
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2015, American Society of Nuclear Cardiology.

Keywords

Dipyridamole
atrioventricular block
sinus arrest

Access to Document

10.1007/s12350-015-0294-1

Cite this

@article{28a9fcc92fcd42aeae631d463ff5e20a,

title = "Conduction abnormalities during dipyridamole stress testing",

abstract = "Pharmacological stress tests using dipyridamole are considered to be safe. However, cases of atrioventricular (AV) block have been reported. We retrospectively analyzed ECG at baseline and during dipyridamole stress tests of 2010 consecutive patients (patients with second or third degree AV block were excluded). At baseline, 350 (17.4%) patients had conduction abnormalities. Following dipyridamole infusion 16 patients (0.8%) developed a transient change in AV conduction (15 patients) and or sinus arrest (1 patient). Compared to patients without baseline conduction abnormalities, patients with any conduction abnormalities at baseline were at a higher risk for the development of AV block after dipyridamole infusion [0.3% vs 3.14%, respectively; P < .0001].",

keywords = "Dipyridamole, atrioventricular block, sinus arrest",

author = "Samia Massalha and Ilya Reizberg and Ora Israel and Michael Kapeliovich and Haitham Sholy and Amjad Koskosi and Zohar Keidar and Ibrahim Marai",

note = "Publisher Copyright: {\textcopyright} 2015, American Society of Nuclear Cardiology.",

year = "2017",

month = apr,

day = "1",

doi = "10.1007/s12350-015-0294-1",

language = "אנגלית",

volume = "24",

pages = "405--409",

journal = "Journal of Nuclear Cardiology",

issn = "1071-3581",

publisher = "American Society of Nuclear Cardiology",

number = "2",

}

TY - JOUR

T1 - Conduction abnormalities during dipyridamole stress testing

AU - Massalha, Samia

AU - Reizberg, Ilya

AU - Israel, Ora

AU - Kapeliovich, Michael

AU - Sholy, Haitham

AU - Koskosi, Amjad

AU - Keidar, Zohar

AU - Marai, Ibrahim

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Pharmacological stress tests using dipyridamole are considered to be safe. However, cases of atrioventricular (AV) block have been reported. We retrospectively analyzed ECG at baseline and during dipyridamole stress tests of 2010 consecutive patients (patients with second or third degree AV block were excluded). At baseline, 350 (17.4%) patients had conduction abnormalities. Following dipyridamole infusion 16 patients (0.8%) developed a transient change in AV conduction (15 patients) and or sinus arrest (1 patient). Compared to patients without baseline conduction abnormalities, patients with any conduction abnormalities at baseline were at a higher risk for the development of AV block after dipyridamole infusion [0.3% vs 3.14%, respectively; P < .0001].

AB - Pharmacological stress tests using dipyridamole are considered to be safe. However, cases of atrioventricular (AV) block have been reported. We retrospectively analyzed ECG at baseline and during dipyridamole stress tests of 2010 consecutive patients (patients with second or third degree AV block were excluded). At baseline, 350 (17.4%) patients had conduction abnormalities. Following dipyridamole infusion 16 patients (0.8%) developed a transient change in AV conduction (15 patients) and or sinus arrest (1 patient). Compared to patients without baseline conduction abnormalities, patients with any conduction abnormalities at baseline were at a higher risk for the development of AV block after dipyridamole infusion [0.3% vs 3.14%, respectively; P < .0001].

KW - Dipyridamole

KW - atrioventricular block

KW - sinus arrest

UR - http://www.scopus.com/inward/record.url?scp=84944916598&partnerID=8YFLogxK

U2 - 10.1007/s12350-015-0294-1

DO - 10.1007/s12350-015-0294-1

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 26494645

AN - SCOPUS:84944916598

SN - 1071-3581

VL - 24

SP - 405

EP - 409

JO - Journal of Nuclear Cardiology

JF - Journal of Nuclear Cardiology

IS - 2

ER -

Conduction abnormalities during dipyridamole stress testing

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this